BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17915955)

  • 1. Development of albumin-binding camptothecin prodrugs using a Peptide positional scanning library.
    Schmid B; Warnecke A; Fichtner I; Jung M; Kratz F
    Bioconjug Chem; 2007; 18(6):1786-99. PubMed ID: 17915955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy.
    Schmid B; Chung DE; Warnecke A; Fichtner I; Kratz F
    Bioconjug Chem; 2007; 18(3):702-16. PubMed ID: 17378599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of albumin-binding doxorubicin prodrugs that are cleaved by prostate-specific antigen.
    Kratz F; Mansour A; Soltau J; Warnecke A; Fichtner I; Unger C; Drevs J
    Arch Pharm (Weinheim); 2005 Oct; 338(10):462-72. PubMed ID: 16211657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, cleavage profile, and antitumor efficacy of an albumin-binding prodrug of methotrexate that is cleaved by plasmin and cathepsin B.
    Warnecke A; Fichtner I; Sass G; Kratz F
    Arch Pharm (Weinheim); 2007 Aug; 340(8):389-95. PubMed ID: 17628030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maleimide-oligo(ethylene glycol) derivatives of camptothecin as albumin-binding prodrugs: synthesis and antitumor efficacy.
    Warnecke A; Kratz F
    Bioconjug Chem; 2003; 14(2):377-87. PubMed ID: 12643748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs.
    Conover CD; Greenwald RB; Pendri A; Shum KL
    Anticancer Drug Des; 1999 Dec; 14(6):499-506. PubMed ID: 10834271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP).
    Graeser R; Chung DE; Esser N; Moor S; Schächtele C; Unger C; Kratz F
    Int J Cancer; 2008 Mar; 122(5):1145-54. PubMed ID: 17973264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activity of camptothecin analogues is enhanced in histocultures of human tumors and human tumor xenografts by modulation of extracellular pH.
    Flowers JL; Hoffman RM; Driscoll TA; Wall ME; Wani MC; Manikumar G; Friedman HS; Dewhirst M; Colvin OM; Adams DJ
    Cancer Chemother Pharmacol; 2003 Sep; 52(3):253-61. PubMed ID: 12783198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivering multiple anticancer peptides as a single prodrug using lysyl-lysine as a facile linker.
    Prasad S; Mathur A; Jaggi M; Mukherjee R
    J Pept Sci; 2007 Jul; 13(7):458-67. PubMed ID: 17559067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evaluation of a novel albumin-binding prodrug of doxorubicin in an orthotopic mouse model of prostate cancer (LNCaP).
    Elsadek B; Graeser R; Esser N; Schäfer-Obodozie C; Tsurumi C; Abu Ajaj K; Warnecke A; Unger C; Saleem T; Kratz F
    Prostate Cancer Prostatic Dis; 2011 Mar; 14(1):14-21. PubMed ID: 21042336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice.
    Schluep T; Cheng J; Khin KT; Davis ME
    Cancer Chemother Pharmacol; 2006 May; 57(5):654-62. PubMed ID: 16133526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivation of carbamate-based 20(S)-camptothecin prodrugs.
    Pessah N; Reznik M; Shamis M; Yantiri F; Xin H; Bowdish K; Shomron N; Ast G; Shabat D
    Bioorg Med Chem; 2004 Apr; 12(8):1859-66. PubMed ID: 15051055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: an in vitro and in vivo evaluation study.
    Elsadek B; Graeser R; Esser N; Schäfer-Obodozie C; Abu Ajaj K; Unger C; Warnecke A; Saleem T; El-Melegy N; Madkor H; Kratz F
    Eur J Cancer; 2010 Dec; 46(18):3434-44. PubMed ID: 20933385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
    J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, and preliminary in vivo tests of new poly(ethylene glycol) conjugates of the antitumor agent 10-amino-7-ethylcamptothecin.
    Guiotto A; Canevari M; Orsolini P; Lavanchy O; Deuschel C; Kaneda N; Kurita A; Matsuzaki T; Yaegashi T; Sawada S; Veronese FM
    J Med Chem; 2004 Feb; 47(5):1280-9. PubMed ID: 14971908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and activity of a folate peptide camptothecin prodrug.
    Henne WA; Doorneweerd DD; Hilgenbrink AR; Kularatne SA; Low PS
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5350-5. PubMed ID: 16901694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship of alkyl 9-nitrocamptothecin esters.
    Cao ZS; Pantazis P; Mendoza J; Early J; Kozielski A; Harris N; Giovanella B
    Acta Pharmacol Sin; 2003 Feb; 24(2):109-19. PubMed ID: 12546717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of normal and tumor tissue uptake of MAG-CPT, a polymer-bound prodrug of camptothecin, in patients undergoing elective surgery for colorectal carcinoma.
    Sarapa N; Britto MR; Speed W; Jannuzzo M; Breda M; James CA; Porro M; Rocchetti M; Wanders A; Mahteme H; Nygren P
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):424-30. PubMed ID: 12904897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioreduction activated prodrugs of camptothecin: molecular design, synthesis, activation mechanism and hypoxia selective cytotoxicity.
    Zhang Z; Tanabe K; Hatta H; Nishimoto S
    Org Biomol Chem; 2005 May; 3(10):1905-10. PubMed ID: 15889173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three new prodrugs for suicide gene therapy using carboxypeptidase G2 elicit bystander efficacy in two xenograft models.
    Friedlos F; Davies L; Scanlon I; Ogilvie LM; Martin J; Stribbling SM; Spooner RA; Niculescu-Duvaz I; Marais R; Springer CJ
    Cancer Res; 2002 Mar; 62(6):1724-9. PubMed ID: 11912146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.